Comparison of platelet inhibition by prasugrel versus ticagrelor over time in patients with acute myocardial infarction Leor PerlNoa Zemer-WassercugEli I. Lev OriginalPaper 02 August 2014 Pages: 1 - 7
A randomised trial of the pharmacodynamic and pharmacokinetic effects of ticagrelor compared with clopidogrel in Hispanic patients with stable coronary artery disease Matthew J. PriceLeonardo ClavijoJuan Maya OriginalPaper Open access 11 October 2014 Pages: 8 - 14
Circulating lipid levels and risk of coronary artery disease in a large group of patients undergoing coronary angiography Daniel E. PlattMichella Ghassibe-SabbaghFGENTCARD Consortium OriginalPaper 01 May 2014 Pages: 15 - 22
Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials Jun ChenHaoyu MengJohn W. Eikelboom OriginalPaper 29 May 2014 Pages: 23 - 34
Weight of the bleeding impact on early and late mortality after percutaneous coronary intervention Gjin NdrepepaElena GuerraAdnan Kastrati OriginalPaper 16 May 2014 Pages: 35 - 42
Hemostatic potential of latex proteases from Tabernaemontana divaricata (L.) R. Br. ex. Roem. and Schult. and Artocarpus altilis (Parkinson ex. F.A. Zorn) Forsberg Maheshwari Kumari SinghR. UshaO. S. Bindhu OriginalPaper 21 January 2015 Pages: 43 - 49
Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion Sharon L. HaleRobert A. Kloner OriginalPaper 14 July 2014 Pages: 50 - 54
d-Dimer elevation and adverse outcomes Rim HalabyChristopher J. PopmaC. Michael Gibson ReviewPaper Open access 09 July 2014 Pages: 55 - 59
Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study Sixten SellengKathleen SellengAndreas Greinacher OriginalPaper 08 July 2014 Pages: 60 - 67
Catastrophic antiphospholipid syndrome presenting with pulmonary hemorrhage: case report Tony WanPeter Tsang Report 04 June 2014 Pages: 68 - 70
In vitro thrombolytic activity of purified streptokinase extracted from Streptococcus equinus VIT_VB2 isolated from bovine milk Vaishnavi BabuC. Subathra Devi OriginalPaper 05 June 2014 Pages: 71 - 78
A validated high-throughput UHPLC-MS/MS assay for accurate determination of rivaroxaban in plasma sample Muzaffar IqbalNasr Y. KhalilMd. Khalid Anwer OriginalPaper 09 August 2014 Pages: 79 - 88
Global coagulation assays: a clinical perspective Ayesha ZiaSarah H. O’Brien OriginalPaper 23 September 2014 Pages: 89 - 94
Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation Matej SamošLucia StančiakováMarián Mokáň OriginalPaper 08 August 2014 Pages: 95 - 100
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials Giuseppe De LucaMaurits T. DirksenGregg W. Stone OriginalPaper 27 June 2014 Pages: 101 - 112
Epidemiological association between migraine and lipoprotein(a): a systematic review Camilla MattiuzziGianfranco CervellinGiuseppe Lippi ReviewPaper 30 April 2014 Pages: 113 - 117
Solvent/detergent plasma: pharmaceutical characteristics and clinical experience Giancarlo Maria LiumbrunoMassimo Franchini ReviewPaper 21 May 2014 Pages: 118 - 128
Selecting an oral anticoagulant for patients with nonvalvular atrial fibrillation Carlos J. Gonzalez QuesadaRobert P. Giugliano OriginalPaper 22 November 2014 Pages: 129 - 138
Management of pulmonary arterial hypertension associated to thalassemia: when pulmonary endarterectomy is the best therapeutical option? A case report Simona RoggeroSilvia VulloCarlo Albera Report 01 May 2014 Pages: 139 - 143
Kimura’s disease associated necrotizing eosinophilic vasculitis presenting with recurrent peripheral arterial occlusive disease: a case report and review of the literature Shun-Neng HsuChun-Feng ChangHsiang-Cheng Chen Report 09 July 2014 Pages: 144 - 147